Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-26-019368
Filing Date
2026-06-03
Accepted
2026-06-03 16:11:21
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 nrxp20260603_424b5.htm 424B5 505975
2 nrx.jpg GRAPHIC 12427
3 nrxlogo.jpg GRAPHIC 1946
  Complete submission text file 0001437749-26-019368.txt   527135
Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)

EIN.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-288205 | Film No.: 261060722
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)